Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.370
+0.055 (4.18%)
At close: Oct 2, 2026, 4:00 PM EDT
1.350
-0.020 (-1.46%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $6.61 million as of October 2, 2026. Its market cap has decreased by -21.55% in one year.
Market Cap
6.61M
Enterprise Value
-980.20K
1-Year Change
-21.55%
Ranking
Category
Stock Price
$1.37
ChartMarket Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $6.61M, a decrease of -99.42%. That is a compound annual growth rate of -62.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 6.61M | -4.45% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 6.61M |
| CollPlant Biotechnologies | 6.50M |
| Can-Fite BioPharma | 6.50M |
| Evogene | 6.32M |
| Creative Medical Technology Holdings | 6.07M |
| Lunai Bioworks | 5.89M |
| Pulmatrix | 5.81M |
| AIM ImmunoTech | 5.78M |